Bayer Says 651 Yaz, Yasmin Blood Clot Lawsuits Have Been SettledApr 27, 2012 | Parker Waichman LLP
Bayer AG continues to settle lawsuits alleging its Yaz and Yasmin birth control pills caused serious, life-threatening blood clots in some young women. According to the company's latest Stockholder Newsletter, Yaz and Yasmin lawsuit settlements have cost the company $142 million so far.
According to Bayer, some 651 lawsuits have been resolved.
“Bayer is only settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case specific analysis of medical records,” the company's report said.
According to a report from Bloomberg News, around 14,000 plaintiffs have filed 11,900 lawsuits over Yaz and Yasmin. About half of the lawsuits allege the drugs caused blood clots that can lead to heart attacks, strokes and even death. Bayer has not indicated a willingness to settle other claims, such as those alleging use of Yaz and Yasmin led to gallbladder disease.
Most of those lawsuits are pending in a multidistrict litigation under way in Illinois federal court alleging that Yaz and Yasmin caused serious side effect injuries, including blood clots. Late last year, the first trials in that litigation, which were scheduled to start in January, were postponed, and the cases were ordered to mediation at Bayer's request.
Earlier this month, the U.S. Food & Drug Administration (FDA) announced that the labels for Yaz, Yasmin and similar birth control pills would be updated to include additional information regarding blood clots, after its review of observational studies indicated that oral contraceptives made with drospirenone might pose a higher risk of blood clots compared to those made with other forms of progestin.